Genzyme Corp entered the industry of Drug Brokers in 0 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000.000 to $499.999.999. The NAICS classifies this business under the code 3254140, which describes it as a Drug Brokers. For further clarification, the SIC classifies this business under the code 5122 and described it as a Drug Brokers. The business provides service to the B2B market.
To acquire more information, please contact Steve Mottola, Senior Vice President by calling (201) 313-9660 during business hours. You can also write to the business’ Branch at 1125 Pleasantview Terrace, Ridgefield, New Jersey NJ 07657. You can also visit the company’s website at genzyme.com. View this business’ social media profiles on Twitter or on Facebbok .
Company: | Genzyme Corp |
Representative: | Steve Mottola, Senior Vice President |
Place of Business: | 1125 Pleasantview Terrace, Ridgefield, NJ 07657 |
Contact Number: | (201) 313-9660 |
Website: | genzyme.com |
Type of Service: | Drug Brokers |
SIC Number: | 5122 |
NAICS Number: | 3254140 |
Locality: | Branch |
Market Type: | B2B (Business to Business) |
Income/Year: | $100.000.000 to $499.999.999 |
Laborers: | 1 to 4 |
Share This Company: |
Genzyme Corp is a company operating from Bergen, New Jersey providing professional Drug Brokers and relevant B2B variables. It was founded in 0 and registered with the SIC code 5122 as Drug Brokers, and with the NAICS code 3254140 as Drug Brokers.
With a current employee count of 1 to 4, Genzyme Corp has gone to report making $100.000.000 to $499.999.999 per annum on its journey towards growth. This company invites you to contact its representative Steve Mottola, Senior Vice President at (201) 313-9660 for related queries, or to locate its Branch using the coordinates 40.82722,-74.01591.
The Branch can also be found at the street address 1125 Pleasantview Terrace in Ridgefield, New Jersey 07657 and can be engaged online through the company website at genzyme.com, the company Twitter , and Facebook page .